Delvaux M - Search Results

1

Evaluation of colonic sensory thresholds in IBS patients using a barostat. Definition of optimal conditions and comparison with healthy subjects.

Bradette M, Delvaux M, Staumont G, Fioramonti J, Bueno L, Frexinos J. Bradette M, et al. Among authors: delvaux m. Dig Dis Sci. 1994 Mar;39(3):449-57. doi: 10.1007/BF02088327. Dig Dis Sci. 1994. PMID: 8131679

2

Drugs affecting visceral sensitivity: ready for the prime time?

Delvaux MM, Gay G. Delvaux MM, et al. Dig Dis. 2006;24(1-2):99-104. doi: 10.1159/000090313. Dig Dis. 2006. PMID: 16699268 Review.

3

The kappa agonist fedotozine relieves hypersensitivity to colonic distention in patients with irritable bowel syndrome.

Delvaux M, Louvel D, Lagier E, Scherrer B, Abitbol JL, Frexinos J. Delvaux M, et al. Gastroenterology. 1999 Jan;116(1):38-45. doi: 10.1016/s0016-5085(99)70226-x. Gastroenterology. 1999. PMID: 9869600 Clinical Trial.

4

Standardization of barostat procedures for testing smooth muscle tone and sensory thresholds in the gastrointestinal tract. The Working Team of Glaxo-Wellcome Research, UK.

Whitehead WE, Delvaux M. Whitehead WE, et al. Among authors: delvaux m. Dig Dis Sci. 1997 Feb;42(2):223-41. doi: 10.1023/a:1018885028501. Dig Dis Sci. 1997. PMID: 9052500

5

Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome.

Delvaux M, Louvel D, Mamet JP, Campos-Oriola R, Frexinos J. Delvaux M, et al. Aliment Pharmacol Ther. 1998 Sep;12(9):849-55. doi: 10.1046/j.1365-2036.1998.00375.x. Aliment Pharmacol Ther. 1998. PMID: 9768527 Clinical Trial.

6

Follow-up of patients with hyperplastic polyps of the large bowel.

Croizet O, Moreau J, Arany Y, Delvaux M, Rumeau JL, Escourrou J. Croizet O, et al. Among authors: delvaux m. Gastrointest Endosc. 1997 Aug;46(2):119-23. doi: 10.1016/s0016-5107(97)70058-0. Gastrointest Endosc. 1997. PMID: 9283860

7

Trimebutine: mechanism of action, effects on gastrointestinal function and clinical results.

Delvaux M, Wingate D. Delvaux M, et al. J Int Med Res. 1997 Sep-Oct;25(5):225-46. doi: 10.1177/030006059702500501. J Int Med Res. 1997. PMID: 9364286 Review.

8

[Colonic motility in the irritable bowel syndrome].

Frexinos J, Bueno L, Fioramonti J, Delvaux M, Staumont G. Frexinos J, et al. Among authors: delvaux m. Gastroenterol Clin Biol. 1990;14(5 ( Pt 2)):18C-23C. Gastroenterol Clin Biol. 1990. PMID: 2210177 Review. French.

9

Oxytocin increases thresholds of colonic visceral perception in patients with irritable bowel syndrome.

Louvel D, Delvaux M, Felez A, Fioramonti J, Bueno L, Lazorthes Y, Frexinos J. Louvel D, et al. Among authors: delvaux m. Gut. 1996 Nov;39(5):741-7. doi: 10.1136/gut.39.5.741. Gut. 1996. PMID: 9014776 Free PMC article. Clinical Trial.

10

Octreotide increases thresholds of colonic visceral perception in IBS patients without modifying muscle tone.

Bradette M, Delvaux M, Staumont G, Fioramonti J, Bueno L, Frexinos J. Bradette M, et al. Among authors: delvaux m. Dig Dis Sci. 1994 Jun;39(6):1171-8. doi: 10.1007/BF02093780. Dig Dis Sci. 1994. PMID: 8200249 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results